Cargando…
Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial
Background. Diuresis is a major therapy for the reduction of congestive symptoms in acute decompensated heart failure (ADHF) patients. We previously reported the efficacy and safety of tolvaptan compared to carperitide in hospitalized patients with ADHF. There were some reports of cardio- and renal-...
Autores principales: | Suzuki, Satoshi, Yoshihisa, Akiomi, Yamaki, Takayoshi, Sugimoto, Koichi, Kunii, Hiroyuki, Nakazato, Kazuhiko, Abe, Yukihiko, Saito, Tomiyoshi, Ohwada, Takayuki, Suzuki, Hitoshi, Saitoh, Shu-ichi, Kubota, Isao, Takeishi, Yasuchika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243738/ https://www.ncbi.nlm.nih.gov/pubmed/25436213 http://dx.doi.org/10.1155/2014/704289 |
Ejemplares similares
-
Acute heart failure volume control multicenter randomized (AVCMA) trial: Comparison of tolvaptan and carperitide
por: Suzuki, Satoshi, et al.
Publicado: (2013) -
Impact of Sleep-Disordered Breathing on Heart Rate Turbulence in Heart Failure Patients
por: Yoshihisa, Akiomi, et al.
Publicado: (2014) -
Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease
por: Sugimoto, Koichi, et al.
Publicado: (2016) -
Elevated exhaled acetone concentration in stage C heart failure patients with diabetes mellitus
por: Yokokawa, Tetsuro, et al.
Publicado: (2017) -
Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2017)